This review explores using nanotechnology to enhance the delivery of neuroprotective phytochemicals from medicinal plants for Alzheimer's disease (AD), addressing issues of bioavailability, solubility, and blood-brain barrier penetration, and highlights the potential of nanocarriers to revolutionize neuroprotective drug delivery and improve patient outcomes.

This study developed a novel mouse model with tamoxifen-inducible knockout of the Gnpat gene, enabling late-onset plasmalogen deficiency to investigate its role in Alzheimer's disease. The model exhibited significant plasmalogen reduction and associated behavioral and nerve function changes, providing a valuable tool for future research on plasmalogen involvement in neurodegeneration and potential therapies.

Update the demographic characteristics of patients with Alzheimer’s disease and their informants in eight Asian countries and compare them from 12 years prior.

Environmental stress from deforestation, driven by rapidly growing palm oil production and agricultural expansion, heightens human-animal interactions, fostering zoonotic diseases. Climate change and altered weather patterns are boosting vector populations and pathogen evolution that enhances the transmission of vector-borne infections.This study evaluates One Health strategies used by southeast Asian countries for brucellosis, anthrax, and scrub typhus